Pharmacists in Madison, MN Accepting Medicare
5 Pharmacists found. Showing 1 - 5
 Kristi Carlson, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 205 6th Ave, Madison, MN 56256 Phone: 320-598-3864 |
Nancy Hinrichsen Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 205 6th Ave, Madison, MN 56256 Phone: 320-598-3864 Fax: 320-598-3181 |
 Zachary Zane Williams, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 205 6th Ave, Madison, MN 56256 Phone: 320-598-3864 |
Mrs. Holly Rock Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 205 6th Ave, Madison, MN 56256 Phone: 320-598-3864 |
Dallas Nyflot Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 205 6th Ave, Madison, MN 56256 Phone: 218-988-2739 |
News Archive
Collaborative study of physical activity patterns, eating habits in colorectal cancer patients
The five hospitals of Meridian Health, a System Partner of The Cancer Institute of New Jersey (CINJ), have joined forces with CINJ in offering a clinical research study that examines physical activity patterns and eating habits in colorectal cancer patients who have recently finished treatment.
Study may help to better understand the pathological process involved in brain diseases
A team of researchers at the Case Western Reserve University School of Medicine has taken a major step toward understanding the mechanisms involved in the formation of large clumps of tau protein, a hallmark of Alzheimer's disease and several other neurodegenerative disorders.
Health Reform Dialogue Coalition releases recommendations for U.S. health care system overhaul
A coalition representing health care firms, patients and medical providers on Friday presented a five-page report to Congress recommending changes to the health care system, CQ HealthBeat reports (Adams, CQ HealthBeat, 3/27).
FDA: Seven MDIs for treating asthma and COPD to be phased out
The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move medication out of the inhaler and into the lungs of patients.
Researchers show how a new drug speeds tissue regeneration in animal models
The concept sounds like the stuff of science fiction: take a pill, and suddenly new tissues grow to replace damaged ones. Researchers at Case Western Reserve and UT Southwestern Medical Center this week announced that they have taken significant steps toward turning this once-improbable idea into a vivid reality.
› Verified 2 days ago